otc

As the US Department of Justice opens a criminal probe into the setting of Libor rates, is this the beginning of the end of shady, illiquid and highly profitable trades that banks make between themselves?

Japanese firm Taisho Pharmaceutical pays $310 million for six Asia-Pacific brands and the Indonesian business of Bristol-Myers, as it seeks to build its presence in the OTC drug market.